Year,Date,FillingDate,NetIncome,Revenue,OperatingIncome,EPSDiluted,GrossProfit,GrossProfitRatio,TotalAssets,CommonStockEquity,CurrentAssets,CurrentLiability,TotalLiability,Inventory,RetainedEarnings,EnterpriseValue,bookValuePerShare,currentRatio,debtToAssets,debtToEquity,roic,shareholdersEquityPerShare,roe,priceToSalesRatio,peRatio,pbRatio,payoutRatio,inventoryTurnover,dividendYield,assetTurnover,quickRatio,returnOnAssets,priceToFreeCashFlowsRatio,grossProfitMargin,epsdilutedGrowth,fiveYNetIncomeGrowthPerShare,fiveYRevenueGrowthPerShare,fiveYShareholdersEquityGrowthPerShare,grossProfitGrowth,netIncomeGrowth,operatingIncomeGrowth,threeYNetIncomeGrowthPerShare,threeYRevenueGrowthPerShare,threeYShareholdersEquityGrowthPerShare,Industry,Sector,Price,MarketCap,AvgVolume,Symbol
2022,2022-03-31,2022-06-29,-563365.0,10073.0,-563365.0,-0.64,10073.0,1.0,85031787.0,84552090.0,84775275.0,0.0,479697.0,0.0,-427845.0,-73096520.3,96.36565159463831,0.0,0.0,0.0,-0.006662934056390564,96.36565159463831,-0.006662934056390564,1158.4969423210564,-20.713994834609892,0.13801598162742046,0.0,0.0,0.0,0.00011846158190230672,0.0,-0.006625345883886928,-22.921450570603604,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,Drug Manufacturers—Specialty & Generic,Healthcare,8.43,52389668,5895,SSIC
TTM,,,,,,,,,,,,,,,,19845641.0,14.294046250550311,0.0,0.0,0.0,-6341.822099310177,14.294046250550311,-0.02665150659695845,0.005198441128985793,-9.299472973353103e-05,0.5897560321434843,0.0,0.0,0.0,111.98974349406345,0.0,-6260.271724404765,-1.9926461420658064,1.24357180746248,,,,,,,,,,,Drug Manufacturers—Specialty & Generic,Healthcare,8.43,52389668,5895,SSIC
